• Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

  • Nov 19 2024
  • Length: 57 mins
  • Podcast

Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Listen for free

View show details

  • Summary

  • Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo, including the following topics:

    • Introduction: PI3K/AKT/PTEN Pathway and Resistance to Endocrine Therapy (0:00)
    • First-Line Therapy for HR-Positive Metastatic Breast Cancer (mBC) Harboring PI3K/AKT/PTEN Mutations (7:04)
    • Treatment Options for Recurrent mBC with PI3K/AKT/PTEN Mutations (24:11)
    • Beyond the Guidelines Survey (35:36)
    • Faculty Case Presentations (51:27)

    CME information and select publications
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available